In silico and pharmacokinetic assessment of echinocystic acid effectiveness in Alzheimer's disease like pathology

References

• Dugger BN, Dickson DW. Pathology of neurodegenerative diseases. Cold Spring Harb. Perspect. Biol. 9(7), a028035 (2017).
   PubMed Web of Science ®Google Scholar
• Weller J, Budson A. Current understanding of Alzheimer's disease diagnosis and treatment. F1000Research 7, 1161 (2018).
   Google Scholar
• Blennow K, Zetterberg H. Biomarkers for Alzheimer's disease: current status and prospects for the future. J. Intern. Med. 284(6), 643–663 (2018).
   PubMed Web of Science ®Google Scholar
• Ouellette J, Lacoste B. From neurodevelopmental to neurodegenerative disorders: the vascular continuum. Front. Aging Neurosci. 13, 749026 (2021).
   PubMed Web of Science ®Google Scholar
• Murphy MP, LeVine H. Alzheimer's disease and the amyloid-β peptide. J. Alzheimer's Dis. 19(1), 311–323 (2010).
   PubMed Web of Science ®Google Scholar
• Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F. Oxidative stress and the amyloid beta peptide in Alzheimer's disease. Redox Biol. 14, 450–464 (2018).
   PubMed Web of Science ®Google Scholar
• Suresh S, Begum RF, Singh SA, Chitra V. Anthocyanin as a therapeutic in Alzheimer's disease: a systematic review of preclinical evidences. Ageing Res. Rev. 76, 101595 (2022).
   PubMed Web of Science ®Google Scholar
• Sadigh-Eteghad S, Sabermarouf B, Majdi A, Talebi M, Farhoudi M, Mahmoudi J. Amyloid-Beta: a crucial factor in Alzheimer's disease. Med. Princ. Pract. 24(1), 1–10 (2015).
   PubMed Web of Science ®Google Scholar
• Singh AS, Vellapandian C. Structure of the bloodߝbrain barrier and its role in the transporters for the movement of substrates across the barriers. Curr. Drug Metab. 24(4), 250–269 (2023).
   PubMed Web of Science ®Google Scholar
• Singh AS, Vellapandian C. The role of plant-based products in the prevention of neurological complications. Drug Metab. Bioanal. Lett. 15(2), 81–92 (2022).
   Google Scholar
• Howland RH. Drug therapies for cognitive impairment and dementia. J. Psychosoc. Nurs. Ment. Health Serv. 48(4), 11–14 (2010).
   Web of Science ®Google Scholar
• Bomasang-Layno E, Bronsther R. Diagnosis and treatment of Alzheimer's disease: Delaware. J. Public Heal. 7(4), 74–85 (2021).
   Google Scholar
• Singh AS, Vellapandian C. Phytochemical studies, antioxidant potential, and identification of bioactive compounds using GC-MS of the ethanolic extract of Luffa cylindrica (L.) fruit. Appl. Biochem. Biotechnol. 194(9), 4018–4032 (2022).
   PubMedGoogle Scholar
• Akinyinka Akinwumi K, Olusoji Eleyowo O, Omowunmi Oladipo O. A review on the ethnobotanical uses, phytochemistry and pharmacology effect of Luffa cylindrica. In: Pharmacognosy – Medicinal Plants [Working Title]. IntechOpen (2021). https://www.intechopen.com/online-first/a-review-on-the-ethnobotanical-uses-phytochemistry-and-pharmacology-effect-of-luffa-cylindrica
   Google Scholar
• Singh AS, Vellapandian C. Phytochemical studies, antioxidant potential, and identification of bioactive compounds using GC-MS of the ethanolic extract of Luffa cylindrica (L.) fruit. Appl. Biochem. Biotechnol. 194(9), 4018–4032 (2022).
   PubMedGoogle Scholar
• Bitencourt-Ferreira G, Pintro VO, de Azevedo WF. Docking with AutoDock4. Methods Mol. Biol. 2053, 125–148 (2019).
   PubMedGoogle Scholar
• Singh SA, Vellapandian C. The promising guide to LC–MS analysis and cholinesterase activity of Luffa cylindrica (L.) fruit using in vitro and in-silico analyses. Futur. J. Pharm. Sci. 9(1), 33 (2023).
   Web of Science ®Google Scholar
• Kumar BS, Anuragh S, Kammala AK, Ilango K. Computer aided drug design approach to screen phytoconstituents of Adhatoda vasica as potential inhibitors of SARS-CoV-2 Main Protease enzyme. Life 12(2), 315–339 (2022).
   PubMedGoogle Scholar
• Begum RF, Mohan S. Insights into vitamin E with combined oral contraceptive on INSR gene in PCOS by Integrating in silico and in vivo approaches. Appl. Biochem. Biotechnol. doi: 10.1007/s12010-023-04710-8 (2023) ( Online ahead of print).
   PubMed Web of Science ®Google Scholar
• Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J. Med. Chem. 58(9), 4066–4072 (2015).
   PubMed Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 42717 (2017).
   PubMed Web of Science ®Google Scholar
• Moka MK, Singh AS, Sumithra M. Computational investigation of four isoquinoline alkaloids against polycystic ovarian syndrome. J. Biomol. Struct. Dyn. 1–13 (2023). https://www.tandfonline.com/doi/full/10.1080/07391102.2023.2222828
   Google Scholar
• Hardjono S, Siswandono S, Andayani R. Evaluation of N-benzoylthiourea derivatives as popssible analgesic agents by predicting their hysicochemical and pharmacokinetic properties, toxicity, and analgesic activity. Indones J. Biotechnol. 22(2), 76 (2018).
   Google Scholar
• Ayati A, Falahati M, Irannejad H, Emami S. Synthesis, in vitro antifungal evaluation and in silico study of 3-azolyl-4-chromanone phenylhydrazones. DARU J. Pharm. Sci. 20(1), 46 (2012).
   Google Scholar
• Filimonov DA, Lagunin AA, Gloriozova TA et al. Prediction of the biological activity spectra of organic compounds using the Pass Online web resource. Chem. Heterocycl. Compd. 50(3), 444–457 (2014).
   Web of Science ®Google Scholar
• Filimonov DA, Rudik AV, Dmitriev AV, Poroikov VV. Computer-aided estimation of biological activity profiles of drug-like compounds taking into account their metabolism in human body. Int. J. Mol. Sci. 21(20), 7492 (2020).
   PubMed Web of Science ®Google Scholar
• Lagunin A, Stepanchikova A, Filimonov D, Poroikov V. PASS: prediction of activity spectra for biologically active substances. Bioinformatics 16(8), 747–748 (2000).
   PubMed Web of Science ®Google Scholar
• Şenkardeş S, Han Mİ, Kulabaş N et al. Synthesis, molecular docking and evaluation of novel sulfonyl hydrazones as anticancer agents and COX-2 inhibitors. Mol. Divers 24(3), 673–689 (2020).
   PubMed Web of Science ®Google Scholar
• Ajala A, Uzairu A, Shallangwa GA, Abechi SE. QSAR, simulation techniques, and ADMET/pharmacokinetics assessment of a set of compounds that target MAO-B as anti-Alzheimer agent. Futur. J. Pharm. Sci. 9(1), 4 (2023).
   Web of Science ®Google Scholar
• Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7(1), 42717 (2017).
   PubMed Web of Science ®Google Scholar
• Husain A, Ahmad A, Khan SA, Asif M, Bhutani R, Al-Abbasi FA. Synthesis, molecular properties, toxicity and biological evaluation of some new substituted imidazolidine derivatives in search of potent anti-inflammatory agents. Saudi Pharm. J. 24(1), 104–114 (2016).
   PubMed Web of Science ®Google Scholar
• Ertl P, Rohde B, Selzer P. Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties. J. Med. Chem. 43(20), 3714–3717 (2000).
   PubMed Web of Science ®Google Scholar
• Khan T, Dixit S, Ahmad R et al. Molecular docking, PASS analysis, bioactivity score prediction, synthesis, characterization and biological activity evaluation of a functionalized 2-butanone thiosemicarbazone ligand and its complexes. J. Chem. Biol. 10(3), 91–104 (2017).
   PubMedGoogle Scholar
• ul Hassan SS, Abbas SQ, Ali F et al. A comprehensive in silico exploration of pharmacological properties, bioactivities, molecular docking, and anticancer potential of Vieloplain F from Xylopia vielana targeting B-Raf kinase. Molecules 27(3), 917 (2022).
   PubMed Web of Science ®Google Scholar
• Madden JC, Enoch SJ, Paini A, Cronin MTD. A review of in silico tools as alternatives to animal testing: principles, resources and applications. Altern. to Lab. Anim. 48(4), 146–172 (2020).
   PubMed Web of Science ®Google Scholar
• Makhouri FR, Ghasemi JB. In silico studies in drug research against neurodegenerative diseases. Curr. Neuropharmacol. 16(6), 664–725 (2018).
   PubMedGoogle Scholar
• Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ, Mattson MP. Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders. Antioxid. Redox Signal. 13(11), 1763–1811 (2010).
   PubMed Web of Science ®Google Scholar
• Tyagi A, Kamal MA, Poddar NK. Integrated pathways of COX-2 and mTOR: roles in cell sensing and Alzheimer's disease. Front. Neurosci. 14, 693 (2020).
   PubMed Web of Science ®Google Scholar
• Heppner FL, Ransohoff RM, Becher B. Immune attack: the role of inflammation in Alzheimer disease. Nat. Rev. Neurosci. 16(6), 358–372 (2015).
   PubMed Web of Science ®Google Scholar
• Akiyama H. Inflammation and Alzheimer's disease. Neurobiol. Aging 21(3), 383–421 (2000).
   PubMed Web of Science ®Google Scholar
• Walker KA, Ficek BN, Westbrook R. Understanding the role of systemic inflammation in Alzheimer's disease. ACS Chem. Neurosci. 10(8), 3340–3342 (2019).
   PubMed Web of Science ®Google Scholar
• Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Giuffrida Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 8(10), 766–775 (2007).
   PubMed Web of Science ®Google Scholar
• Chew H, Solomon VA, Fonteh AN. Involvement of lipids in Alzheimer's disease pathology and potential therapies. Front. Physiol. 11, 598 (2020).
   PubMed Web of Science ®Google Scholar
• Zhu T-B, Zhang Z, Luo P et al. Lipid metabolism in Alzheimer's disease. Brain Res. Bull. 144, 68–74 (2019).
   PubMed Web of Science ®Google Scholar
• Hone E, Lim F, Martins IJ. Fat and lipid metabolism and the involvement of Apolipoprotein E in Alzheimer'sdisease. In: Neurodegeneration and Alzheimer's Disease. John Wiley & Sons, Ltd, Chichester, UK, 189–231 (2019).
   Google Scholar
• Eckert GP, Müller WE, Wood GW. Cholesterol-lowering drugs and Alzheimer's disease. Future Lipidol. 2(4), 423–432 (2007).
   Web of Science ®Google Scholar
• Chen B, Zhao Y, Li W, Hang J, Yin M, Yu H. Echinocystic acid provides a neuroprotective effect via the PI3K/AKT pathway in intracerebral haemorrhage mice. Ann. Transl. Med. 8(1), 6 (2020).
   PubMed Web of Science ®Google Scholar
• Montine TJ, Neely MD, Quinn JF et al. Lipid peroxidation in aging brain and Alzheimer's disease 1,2 1Guest Editors: Mark A. Smith and George Perry 2This article is part of a series of reviews on “Causes and Consequences of Oxidative Stress in Alzheimer's Disease”. The full list of papers may b. Free Radic. Biol. Med. 33(5), 620–626 (2002).
   PubMed Web of Science ®Google Scholar
• Yu H, Li W, Cao X et al. Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway. Eur. J. Pharmacol. 861, 172610 (2019).
   PubMed Web of Science ®Google Scholar
• Kuratsune H, Yamaguti K, Takahashi M, Misaki H, Tagawa S, Kitani T. Acylcarnitine deficiency in chronic fatigue syndrome. Clin. Infect. Dis. 18(Suppl. 1), S62–S67 (1994).
   PubMedGoogle Scholar
• Calabrese V, Cornelius C, Dinkova-Kostova AT, Calabrese EJ. Vitagenes, cellular stress response, and acetylcarnitine: relevance to hormesis. Bio Factors 35(2), 146–160 (2009).
   PubMed Web of Science ®Google Scholar
• Jung I-H, Jang S-E, Joh E-H, Chung J, Han MJ, Kim D-H. Lancemaside A isolated from Codonopsis lanceolata and its metabolite echinocystic acid ameliorate scopolamine-induced memory and learning deficits in mice. Phytomedicine 20(1), 84–88 (2012).
   PubMed Web of Science ®Google Scholar